鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02251 鹰瞳科技-B

休市中 03-20 16:08:47

11.200

-0.260

-2.27%

最高11.700	最低11.200	成交量1.62万
今开11.700	昨收11.460	日振幅4.36%
总市值11.42亿	流通市值11.42亿	总股本1.02亿
成交额18.52万	换手率0.02%	流通股本1.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02251","market":"HK","secType":"STK","nameCN":"鹰瞳科技-B","latestPrice":11.2,"timestamp":1773994127123,"preClose":11.46,"halted":0,"volume":16200,"delay":0,"changeRate":-0.022687609075043764,"floatShares":102000000,"shares":102000000,"eps":-2.499702,"marketStatus":"休市中","change":-0.26,"latestTime":"03-20 16:08:47","open":11.7,"high":11.7,"low":11.2,"amount":185222,"amplitude":0.04363,"askPrice":11.47,"askSize":5100,"bidPrice":11.2,"bidSize":4900,"shortable":0,"etf":0,"ttmEps":-1.899223,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":7,"adr":0,"listingDate":1636041600000,"exchange":"SEHK","adjPreClose":11.46,"openAndCloseTimeList":[[1773970200000,1773979200000],[1773982800000,1773993600000]],"volumeRatio":0.03133947226725127,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02251","defaultTab":"news","newsList":[{"id":"2620209887","title":"德适今日启动港股IPO招股，将成“医学影像大模型第一股”","url":"https://stock-news.laohu8.com/highlight/detail?id=2620209887","media":"新浪科技","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620209887?lang=zh_cn&edition=full","pubTime":"2026-03-20 10:56","pubTimestamp":1773975360,"startTime":"0","endTime":"0","summary":"新浪科技讯 3月20日上午消息，杭州德适生物科技股份有限公司正式启动港股IPO招股，计划将于3月30日在港交所主板挂牌上市。此次IPO拟发行7，999，200股H股，发售价区间为每股95.6至112.5港元。其中香港公开发售占10%，国际发售占90%，至多可通过本次IPO募集约9亿港元。　　本次招股将于3月25日截止。在港交所主板挂牌上市后，德适将成为“医学影像大模型第一股”。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/newstock/2026-03-20/doc-inhrqyie0914872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","BK4588","BK1189","02251","VXUS"],"gpt_icon":0},{"id":"2620036802","title":"“医学影像大模型第一股”问鼎港交所：德适生物（2526.HK）收入暴涨469.8%的底层逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2620036802","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620036802?lang=zh_cn&edition=full","pubTime":"2026-03-20 09:15","pubTimestamp":1773969351,"startTime":"0","endTime":"0","summary":"作为港股市场稀缺的医疗AI核心资产，德适生物不仅为二级市场提供了兼具稀缺性与确定性的投资标的，更将引领中国医疗AI技术从“跟跑”迈向“领跑”，为健康中国建设注入强劲的数智动能。","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/137.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/137.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4126064","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1189","02526","02251"],"gpt_icon":0},{"id":"2620776732","title":"德适-B(02526)3月20日至3月25日招股拟全球发售799.92万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620776732","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620776732?lang=zh_cn&edition=full","pubTime":"2026-03-20 07:28","pubTimestamp":1773962939,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德适-B 于2026年3月20日-2026年3月25日招股，拟全球发售799.92万股H股，其中香港发售占约10%，国际发售占约90%;发售价每股95.6-112.5港元。得益于需求不断增长、AI技术进步、医院信息系统发展以及利好政策，中国智能医学影像市场的市场规模预计到2030年将增加至人民币401亿元，2024年至2030年的复合年增长率为60.2%，到2035年将进一步增加至人民币781亿元，2030年至2035年的复合年增长率为14.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416271.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AIYY","VGT","AI","BK4023","BK1189","BK4551","BK4528","BK4587","BK4588","BK4585","02251","BK4543"],"gpt_icon":0},{"id":"2619109370","title":"新股消息 | 德适生物成功通过港交所聆讯  冲刺“医学影像大模型第一股”","url":"https://stock-news.laohu8.com/highlight/detail?id=2619109370","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619109370?lang=zh_cn&edition=full","pubTime":"2026-03-15 20:12","pubTimestamp":1773576745,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港交所3月15日披露，杭州德适生物科技股份有限公司成功通过港交所主板上市聆讯，冲刺“医学影像大模型第一股”。作为AI医疗赛道龙头，德适生物将独享行业爆发的核心红利。此次通过港交所聆讯，德适生物将借助资本市场力量，推动AI 医学影像向更精准、更高效、更普惠方向发展，成为引领全球精准诊断新时代的中坚力量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414029.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","02251","HEXmain","91016"],"gpt_icon":0},{"id":"2618892902","title":"鹰瞳科技-B盘中异动 快速下挫5.62%报11.410港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618892902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618892902?lang=zh_cn&edition=full","pubTime":"2026-03-12 10:54","pubTimestamp":1773284088,"startTime":"0","endTime":"0","summary":"2026年03月12日早盘10时54分，鹰瞳科技-B股票出现波动，股价快速下跌5.62%。截至发稿，该股报11.410港元/股，成交量800股，换手率0.00%，振幅6.45%。资金方面，该股资金流入6000港元，流出1131港元。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体跌幅为0.16%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312105448a462b14d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312105448a462b14d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2617571526","title":"鹰瞳科技-B盘中异动 快速上涨7.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617571526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617571526?lang=zh_cn&edition=full","pubTime":"2026-03-05 11:09","pubTimestamp":1772680161,"startTime":"0","endTime":"0","summary":"2026年03月05日早盘11时09分，鹰瞳科技-B股票出现波动，股价急速拉升7.05%。截至发稿，该股报11.990港元/股，成交量100股，换手率0.00%，振幅0.00%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.66%。其相关个股中，华检医疗、鹰瞳科技-B、微创机器人-B涨幅较大，振幅较大的相关个股有健世科技-B、GUANZE MEDICAL、微创机器人-B，振幅分别为13.28%、9.23%、7.45%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030511092197a81ead&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030511092197a81ead&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2613202375","title":"春晚机器人引爆港股，一文锁定A股核心产业链（附股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2613202375","media":"21财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613202375?lang=zh_cn&edition=full","pubTime":"2026-02-23 15:00","pubTimestamp":1771830000,"startTime":"0","endTime":"0","summary":"春晚带来的热度直接传导至消费端，各大电商平台机器人产品销量迎来爆发式增长。春晚开播两小时内，京东机器人搜索量环比增长超300%，客服问询量增长460%，订单量增长150%。与春晚热度同步，机器人产业链近期利好不断。越疆日前正式启动第三批全尺寸工业人形机器人Atom的量产交付，这意味着其人形机器人加速迈入规模化场景应用的全新阶段。国海证券认为，人形机器人产业或迎来 “ChatGPT 时刻”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223150728a4be45a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223150728a4be45a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02432","01316","BK1189","09880","00826","BK1183","00522","02251","688347","02498","01347","BK1179","BK1613"],"gpt_icon":1},{"id":"2609591035","title":"鹰瞳科技-B盘中异动 大幅上涨10.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609591035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609591035?lang=zh_cn&edition=full","pubTime":"2026-02-06 13:34","pubTimestamp":1770356080,"startTime":"0","endTime":"0","summary":"2026年02月06日下午盘13时34分，鹰瞳科技-B股票出现波动，股价快速拉升10.27%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.11%。其相关个股中，加和国际控股-新、君百延集团、健世科技-B涨幅较大，振幅较大的相关个股有紫元元、加和国际控股-新、华检医疗，振幅分别为10.61%、9.68%、9.38%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020613344097a524fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020613344097a524fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2604618256","title":"光环褪去，鹰瞳科技掉队","url":"https://stock-news.laohu8.com/highlight/detail?id=2604618256","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604618256?lang=zh_cn&edition=full","pubTime":"2026-01-19 17:30","pubTimestamp":1768815016,"startTime":"0","endTime":"0","summary":"当AI制药交易不断刷新行业想象空间时，鹰瞳科技（02251）正在经历一场现实的考验。2026年初，赛诺菲、施维雅等跨国药企密集加码AI制药合作，动辄数十亿美元的交易规模，使“AI+药物研发”成为资本市场最具确定性的叙事之一。相比之下，2021年率先登陆港股、曾被视为医疗AI商业化样本的鹰瞳科技却逐渐淡出聚光灯中心。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601193623386028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2603671228","title":"从“流量链接”到“价值共享”：第三方医学影像行业的破局新路","url":"https://stock-news.laohu8.com/highlight/detail?id=2603671228","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603671228?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:05","pubTimestamp":1768435510,"startTime":"0","endTime":"0","summary":"近年来，互联网医疗与第三方医疗服务的合作逐步深化，从最初的消费医疗领域迈向医疗核心地带，实现了从“轻关联”到“强关联”的跨越。如今，随着健康需求升级与技术成熟，合作进入重医疗属性且数据互联的“强关联”阶段，重要标志是互联网医疗与第三方医学影像机构的深度协同。值得注意的是，与其他第三方医疗服务机构不同，一脉阳光通过建设医学影像区域共享中心和专科医联体，已成功将三甲公立医院的影像诊断能力延伸至基层。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115083043a4c50612&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115083043a4c50612&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1247","BK1515","02251","BK1219","BK1189","BK1617","BK1142","BK1571","BK1615","01833"],"gpt_icon":0},{"id":"2603659416","title":"中邮证券：AI医疗行业加速发展 在制药、辅助诊断、医疗服务等领域步入成熟阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2603659416","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603659416?lang=zh_cn&edition=full","pubTime":"2026-01-14 11:41","pubTimestamp":1768362075,"startTime":"0","endTime":"0","summary":"AI在制药、医疗影像、辅助诊疗等领域正步入成熟应用，推动产业链价值提升，医疗AI三类证审批加速进一步助力行业持续扩张。海外AI医疗公司业绩高增预期及全球业内头部公司持续加大投入，有望映射国内同类公司未来业绩预期。AI在制药、辅助诊断、医疗服务等领域步入成熟阶段在制药领域，凭借AI技术平台强大的数据分析和模型预测能力，相关公司在分子设计和药物筛选方面能够大幅提升药物的研发效率和成功率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114114423a4c15857&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"19a45d98d676f675f3dd1dad1f11fa69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114114423a4c15857&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02506","02251","01477","BK1141","BK1617","02228","BK1191","BK1574"],"gpt_icon":1},{"id":"2603575501","title":"鹰瞳科技-B盘中异动 大幅拉升6.00%报13.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603575501","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603575501?lang=zh_cn&edition=full","pubTime":"2026-01-13 09:46","pubTimestamp":1768268791,"startTime":"0","endTime":"0","summary":"2026年01月13日早盘09时46分，鹰瞳科技-B股票出现异动，股价急速上涨6.00%。截至发稿，该股报13.250港元/股，成交量1.48万股，换手率0.01%，振幅6.00%。资金方面，该股资金流入6.4537万港元，流出9.2184万港元。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.25%。其相关个股中，鹰瞳科技-B、微创心通-B、佳兆业健康涨幅较大，振幅较大的相关个股有百心安-B、隽泰控股、佳兆业健康，振幅分别为13.54%、8.62%、8.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113094631953c7d19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113094631953c7d19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2601336622","title":"港股异动 | 鹰瞳科技-B(02251)现跌超5% 公司自上市以来长期处于亏损状态","url":"https://stock-news.laohu8.com/highlight/detail?id=2601336622","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601336622?lang=zh_cn&edition=full","pubTime":"2026-01-08 10:16","pubTimestamp":1767838608,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，鹰瞳科技-B(02251)现跌超5%，截至发稿，跌5.42%，报11.51港元。消息面上，进入2026年，市场逐步关注企业2025年度业绩。鹰瞳科技2025年中期业绩显示，营业额8371.3万元人民币，同比跌10.7%；纯利44.3万元。值得注意的是，鹰瞳科技自上市以来长期处于亏损状态。统计数据显示，2022至2024年鹰瞳科技年度亏损累计高达5.94亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390204.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2601082237","title":"鹰瞳科技-B盘中异动 早盘股价大跌8.71%报11.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601082237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601082237?lang=zh_cn&edition=full","pubTime":"2026-01-07 09:31","pubTimestamp":1767749499,"startTime":"0","endTime":"0","summary":"2026年01月07日早盘09时31分，鹰瞳科技-B股票出现异动，股价急速下跌8.71%。截至发稿，该股报11.000港元/股，成交量100股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出1100港元。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.01%。其相关个股中，润迈德-B、今海医疗科技、归创通桥涨幅较大，振幅较大的相关个股有归创通桥、爱康医疗、微创医疗，振幅分别为9.10%、2.18%、1.90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107093139953c1c62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107093139953c1c62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2601470885","title":"鹰瞳科技-B盘中异动 股价大跌7.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601470885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601470885?lang=zh_cn&edition=full","pubTime":"2026-01-05 11:11","pubTimestamp":1767582670,"startTime":"0","endTime":"0","summary":"2026年01月05日早盘11时11分，鹰瞳科技-B股票出现波动，股价大幅下跌7.15%。截至发稿，该股报11.550港元/股，成交量3.66万股，换手率0.04%，振幅3.62%。鹰瞳科技-B股票所在的医疗设备及用品行业中，整体涨幅为0.27%。其相关个股中，微创脑科学、心玮医疗-B、微创心通-B涨幅较大，振幅较大的相关个股有心玮医疗-B、微创脑科学、微创心通-B，振幅分别为18.41%、14.60%、12.17%。鹰瞳科技-B公司简介：北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105111110953bfa24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105111110953bfa24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"1197603618","title":"北京鹰瞳科技（02251）回购1.35万股股份，总额约15.73万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197603618","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197603618?lang=zh_cn&edition=full","pubTime":"2025-12-30 18:52","pubTimestamp":1767091926,"startTime":"0","endTime":"0","summary":"北京鷹瞳科技發展股份有限公司于2025年12月30日公布翌日披露报表，显示公司于当日回购13,500股H股股份，约占先前已发行H股总数的0.013%。此次回购价格区间为每股11.6港元至12港元，合计支付总额约15.73万港元。完成后，公司已发行股份总数保持在103,568,013股，其中102,481,213股为流通股，库藏股持有1,086,800股。根据公告，此次回购基于公司于2025年6月27日通过的购回授权。公司确认已遵守香港联合交易所有限公司证券上市规则及其他相关法规要求。公告由董事张大磊签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"gpt_icon":0},{"id":"1104228830","title":"北京鹰瞳科技（02251）回购17,200股H股，总金额约20.51万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1104228830","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104228830?lang=zh_cn&edition=full","pubTime":"2025-12-29 19:22","pubTimestamp":1767007324,"startTime":"0","endTime":"0","summary":"北京鹰瞳科技发展股份有限公司于2025年12月29日公布翌日披露报表，披露当日回购股份事项。根据公告，公司于2025年12月29日于香港联合交易所有限公司按每股11.87至11.95港元的价格区间，回购H股17,200股，占回购前已发行股份102,511,913股的约0.017%，支付总金额约205,106港元。公司回购授权于2025年6月27日通过，可回购股份总数为10,315,601股，截至目前已累计回购661,300股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"gpt_icon":0},{"id":"2595836782","title":"鹰瞳科技-B(02251)12月29日斥资20.51万港元回购1.72万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595836782","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595836782?lang=zh_cn&edition=full","pubTime":"2025-12-29 19:19","pubTimestamp":1767007178,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布公告，于2025年12月29日，该公司斥资20.51万港元回购1.72万股股份，每股回购价格为11.87-11.95港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386667.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2593944268","title":"智通港股回购统计|12月24日","url":"https://stock-news.laohu8.com/highlight/detail?id=2593944268","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593944268?lang=zh_cn&edition=full","pubTime":"2025-12-24 09:10","pubTimestamp":1766538601,"startTime":"0","endTime":"0","summary":"其中，回购金额最大的为腾讯控股，回购数量105.10 万，回购金额6.36 亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385264.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01919","02416","06826","01458","01810","02598","00947","01773","01907","02886","00314","00732","02251","01588","00909","06078","09923","02392","02367","00799","02419","02678","01672","02299","06868","02219","02167","09857","00345","03888","00697","00700","01995","02038","02018","02121","00434","01600","01024","02171","06100","09959","01583","01651","01317","00175","02869","09878","09896","09886"],"gpt_icon":1},{"id":"2593073482","title":"鹰瞳科技-B(02251)12月22日耗资约17.07万港元回购1.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2593073482","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593073482?lang=zh_cn&edition=full","pubTime":"2025-12-22 20:29","pubTimestamp":1766406574,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)公布，2025年12月22日耗资约17.07万港元回购1.45万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","BK1189"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.05},{"period":"1month","weight":-0.0931},{"period":"3month","weight":-0.062},{"period":"6month","weight":-0.2583},{"period":"1year","weight":-0.2513},{"period":"ytd","weight":-0.0201}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0535},{"period":"3month","weight":-0.0161},{"period":"6month","weight":-0.0478},{"period":"1year","weight":0.0437},{"period":"ytd","weight":-0.0138}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京鹰瞳科技发展股份有限公司是一家中国公司，主要专注于提供人工智能视网膜影像识别的早期检测诊断及健康风险评估解决方案。该公司的产品管线包括为医疗机构和大健康领域提供的眼底诊断人工智能SaMD、健康风险评估系统以及相应的智能硬件设备，打造了集软件和硬件于一体的解决方案。该公司还推出了针对儿童和青少年近视及斜弱视问题的人工智能治疗产品，实现了从检测、评估到治疗的一站式解决方案。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.071183},{"month":2,"riseRate":0.8,"avgChangeRate":0.116001},{"month":3,"riseRate":0.2,"avgChangeRate":-0.068515},{"month":4,"riseRate":0,"avgChangeRate":-0.05861},{"month":5,"riseRate":0.5,"avgChangeRate":-0.081691},{"month":6,"riseRate":0.5,"avgChangeRate":0.014792},{"month":7,"riseRate":0.25,"avgChangeRate":-0.034393},{"month":8,"riseRate":0.5,"avgChangeRate":-0.020416},{"month":9,"riseRate":0.25,"avgChangeRate":-0.059637},{"month":10,"riseRate":0.25,"avgChangeRate":-0.013194},{"month":11,"riseRate":0.75,"avgChangeRate":0.109538},{"month":12,"riseRate":0.4,"avgChangeRate":-0.09117}],"exchange":"SEHK","name":"鹰瞳科技-B","nameEN":"AIRDOC-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鹰瞳科技-B,02251,鹰瞳科技-B股票,鹰瞳科技-B股票老虎,鹰瞳科技-B股票老虎国际,鹰瞳科技-B行情,鹰瞳科技-B股票行情,鹰瞳科技-B股价,鹰瞳科技-B股市,鹰瞳科技-B股票价格,鹰瞳科技-B股票交易,鹰瞳科技-B股票购买,鹰瞳科技-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}